Home › Trial NCT01440374
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
- Trial IDNCT01440374
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorNovartis Pharmaceuticals
- Enrollment162
- Start date2011-09
- ConditionsThrombocytopaenia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.